641 related articles for article (PubMed ID: 17363519)
21. Drug delivery to the central nervous system: a review.
Misra A; Ganesh S; Shahiwala A; Shah SP
J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
[TBL] [Abstract][Full Text] [Related]
22. [The blood-brain barrier: implications for chemotherapy in brain tumors].
Boaziz C; Breau JL; Morère JF; Israël L
Pathol Biol (Paris); 1991 Oct; 39(8):789-95. PubMed ID: 1762838
[TBL] [Abstract][Full Text] [Related]
23. Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.
Strazielle N; Khuth ST; Ghersi-Egea JF
Adv Drug Deliv Rev; 2004 Oct; 56(12):1717-40. PubMed ID: 15381331
[TBL] [Abstract][Full Text] [Related]
24. Polymeric nanoparticles for the drug delivery to the central nervous system.
Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
[TBL] [Abstract][Full Text] [Related]
25. Immunotoxins for central nervous system malignancy.
Youle RJ
Semin Cancer Biol; 1996 Apr; 7(2):65-70. PubMed ID: 8740561
[TBL] [Abstract][Full Text] [Related]
26. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
27. Drug delivery to brain tumours: challenges and progress.
Ningaraj NS
Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
[TBL] [Abstract][Full Text] [Related]
28. Peptide and peptide analog transport systems at the blood-CSF barrier.
Smith DE; Johanson CE; Keep RF
Adv Drug Deliv Rev; 2004 Oct; 56(12):1765-91. PubMed ID: 15381333
[TBL] [Abstract][Full Text] [Related]
29. Nature and consequences of mammalian brain and CSF efflux transporters: four decades of progress.
Spector R
J Neurochem; 2010 Jan; 112(1):13-23. PubMed ID: 19860860
[TBL] [Abstract][Full Text] [Related]
30. Advances in strategies to improve drug delivery to brain tumors.
Newton HB
Expert Rev Neurother; 2006 Oct; 6(10):1495-509. PubMed ID: 17078789
[TBL] [Abstract][Full Text] [Related]
31. Systemic chemotherapy for a primary germ cell tumor of the brain: a pharmacokinetic study.
Ginsberg S; Kirshner J; Reich S; Panasci L; Finkelstein T; Fandrich S; Fitzpatrick A; Shechtman L; Comis R
Cancer Treat Rep; 1981; 65(5-6):477-83. PubMed ID: 6165472
[TBL] [Abstract][Full Text] [Related]
32. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
Stukel JM; Caplan MR
Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
[TBL] [Abstract][Full Text] [Related]
33. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours.
Koukourakis MI; Koukouraki S; Fezoulidis I; Kelekis N; Kyrias G; Archimandritis S; Karkavitsas N
Br J Cancer; 2000 Nov; 83(10):1281-6. PubMed ID: 11044350
[TBL] [Abstract][Full Text] [Related]
34. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).
van Vulpen M; Kal HB; Taphoorn MJ; El-Sharouni SY
Oncol Rep; 2002; 9(4):683-8. PubMed ID: 12066192
[TBL] [Abstract][Full Text] [Related]
35. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics.
Mannermaa E; Vellonen KS; Urtti A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1136-63. PubMed ID: 17081648
[TBL] [Abstract][Full Text] [Related]
36. Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.
Parrish KE; Sarkaria JN; Elmquist WF
Clin Pharmacol Ther; 2015 Apr; 97(4):336-46. PubMed ID: 25669487
[TBL] [Abstract][Full Text] [Related]
37. Drug delivery to the brain using polymers.
Domb A; Maniar M; Bogdansky S; Chasin M
Crit Rev Ther Drug Carrier Syst; 1991; 8(1):1-17. PubMed ID: 1868550
[TBL] [Abstract][Full Text] [Related]
38. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
Kemper EM; Boogerd W; Thuis I; Beijnen JH; van Tellingen O
Cancer Treat Rev; 2004 Aug; 30(5):415-23. PubMed ID: 15245774
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system.
Mellett LB
Cancer Treat Rep; 1977 Jul; 61(4):527-31. PubMed ID: 884690
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting delivery of antiviral drugs to the brain.
Strazielle N; Ghersi-Egea JF
Rev Med Virol; 2005; 15(2):105-33. PubMed ID: 15546130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
